ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RVNC Revance Therapeutics Inc

4.93
-0.01 (-0.20%)
Last Updated: 10:50:56
Delayed by 15 minutes

Revance Therapeutics Financial Summary

The current RVNC market cap is 434.9M. The company's latest EPS is USD -3.6727 and P/E is -1.34.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 29.02M49.92M49.33M58.13M56.78M
Operating Income -77.48M-144.41M-58.03M-65.5M-139.29M
Net Income -84.69M-145.95M-59.79M-67.32M-141.18M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 413k15.33M77.8M132.57M234.04M
Operating Income -164.46M-273.16M-274.68M-341.96M-316.78M
Net Income -159.43M-282.09M-281.31M-356.42M-323.99M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 711.59M581.9M547.8M597.54M532.49M
Total Liabilities 565.88M569.3M574.47M570.75M638.69M
Total Equity 145.71M12.6M-26.67M26.79M-106.2M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 340.29M720.22M531.16M581.9M478.45M
Total Liabilities 114.8M345.93M462.69M569.3M630.06M
Total Equity 225.49M374.29M68.47M12.6M-151.6M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -163.37M-193.55M-69.5M-122.88M-173.84M
Investing -179.76M-138.8M95.32M55.78M107.37M
Financing 337.87M331.69M3.27M100.74M138.2M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -106.16M-178.5M-221.54M-193.55M-216.58M
Investing -17.59M12.13M-29.67M-138.8M109.74M
Financing 221.66M331.48M29.87M331.69M136.57M
Market Cap 434.9M
Price to Earnings Ratio -1.34
Price to Sales Ratio 1.85
Price to Cash Ratio 3.15
Price to Book Ratio -2.86
Dividend Yield -

Share Statistics

Shares Outstanding 88.21M
Average Volume (1 week) 1.31M
Average Volume (1 Month) 2.38M
52 Week Change -84.84%
52 Week High 37.98
52 Week Low 4.57
Spread (Intraday) 0.01 (0.2%)

Company Info

Company Name Revance Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.revance.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock